Study finds a link between maternal obesity and diabetes and a significant increase in the risk of autism spectrum disorder in children.
Maternal obesity and diabetes are linked to an increased risk of autism spectrum disorder (ASD), according to a study published in Pediatrics.
Women with obesity and pregestational diabetes or obesity and gestational diabetes had a significantly increased risk of offspring ASD, researchers from Johns Hopkins University found. There was a similar pattern of increased risk of intellectual disabilities.
"It's important for us to now try to figure out what is it about the combination of obesity and diabetes that is potentially contributing to sub-optimal fetal health," study co-author M. Daniele Fallin, PhD, director of the Wendy Klag Center for Autism and Developmental Disabilities at the Bloomberg School and chair of the Department of Mental Health, said in a statement.
The researchers examined records of 2734 children who completed at least 1 postnatal study visit at Boston Medical Center between 1998 and 2014. Risks of ASD and other developmental disabilities were compared among groups defined by the mother’s prepregnancy obesity and diabetes status. Overall, they identified 102 diagnoses of ASD.
Obese women with diabetes were more than 4 times as likely to have children with autism. Unfortunately, it is still unknown why diabetes and obesity in mothers contributes to ASD risk.
Johns Hopkins pointed out the importance of this research as the prevalence of autism has “skyrocketed” at the same time that obesity and diabetes have reached epidemic levels in women of child-bearing age.
"In order to prevent autism, we may need to consider not only pregnancy, but also pre-pregnancy health," Dr Fallin said.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More